IP Library Granted Patent US 7,241,282
Granted Patent B2
US 7,241,282 · App. 10/704,377 · Granted Jul 10, 2007

Compositions and methods for prolonging survival of platelets

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,282
App. No.
10/704,377
Granted
Jul 10, 2007
Kind
B2
Abstract

The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.

Claims (5)

1. A device for collecting and processing platelets comprising: a container for collecting platelets; at least one satellite container in fluid communication with the container; and at least one glycan modifying agent in the at least one satellite container, wherein the at least one glycan modifying agent is UDP-galactose.

2. The device of claim 1 , wherein the at least one glycan modifying agent in the satellite container is present in sufficient amounts to preserve a plurality of platelets collected in the container for collecting platelets.

3. The device of claim 2 , wherein the satellite container is connected to the container by a breakable seal.

4. The device of claim 1 , wherein the container for collecting platelets further comprises plasma containing a plurality of platelets.

5. The device of claim 1 further comprising at least one additional glycan modifying agent in the at least one satellite container, wherein the at least one additional glycan modifying agent is selected from the group consisting of: D-glucose, methyl-α-D-glucopyranoside, methyl-β-D-glucopyranoside, N-acetyl-β-glucosamine, and N-acetyl-glucosamine.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2020
From: PIERCE ATWOOD LLP
To: VELICO MEDICAL, INC.
Reel/Frame 053305/0343 →
CONFIRMATORY LICENSE Recorded Apr 12, 2017
From: PARTNERS HEALTHCARE INNOVATION
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 041984/0694 →
SECURITY INTEREST Recorded Jun 27, 2014
From: VELICO MEDICAL, INC.
To: PIERCE ATWOOD LLP
Reel/Frame 033246/0316 →
CONFIRMATORY LICENSE Recorded Jun 12, 2009
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022817/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2005
From: CLAUSEN, HENRIK
To: ZYMEQUEST, INC.
Reel/Frame 015956/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2004
From: STOSSEL, THOMAS P.; HARTWIG, JOHN H.; HOFFMEISTER, KARIN M.
To: BRIGHAM AND WOMEN'S HOSPITAL, INC., THE
Reel/Frame 014687/0546 →